Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8ZB6

Yeast-expressed polio type 2 stabilized virus-like particles

8ZB6 の概要
エントリーDOI10.2210/pdb8zb6/pdb
EMDBエントリー39895
分子名称VP1, VP3, VP2, ... (4 entities in total)
機能のキーワードpoliovirus type 2, virus-like particles, compact state, viral protein
由来する生物種Poliovirus 2
詳細
タンパク質・核酸の鎖数3
化学式量合計89860.86
構造登録者
Hong, Q.,Cong, Y. (登録日: 2024-04-26, 公開日: 2024-09-18, 最終更新日: 2025-07-23)
主引用文献Hong, Q.,Wang, S.,Wang, X.,Han, W.,Chen, T.,Liu, Y.,Cheng, F.,Qin, S.,Zhao, S.,Liu, Q.,Cong, Y.,Huang, Z.
Vaccine Potency and Structure of Yeast-Produced Polio Type 2 Stabilized Virus-like Particles.
Vaccines (Basel), 12:-, 2024
Cited by
PubMed Abstract: Poliovirus (PV) is on the brink of eradication due to global vaccination programs utilizing live-attenuated oral and inactivated polio vaccines. Recombinant PV virus-like particles (VLPs) are emerging as a safe next-generation vaccine candidate for the impending polio-free era. In this study, we investigate the production, antigenicity, thermostability, immunogenicity, and structures of VLPs derived from PV serotype 2 (PV2) wildtype strain and thermally stabilized mutant (wtVLP and sVLP, respectively). Both PV2 wtVLP and sVLP are efficiently produced in yeast. The PV2 sVLP displays higher levels of D-antigen and significantly enhanced thermostability than the wtVLP. Unlike the wtVLP, the sVLP elicits neutralizing antibodies in mice at levels comparable to those induced by inactivated polio vaccine. The addition of an aluminum hydroxide adjuvant to sVLP results in faster induction and a higher magnitude of neutralizing antibodies. Furthermore, our cryo-EM structural study of both sVLP and wtVLP reveals a native conformation for the sVLP and a non-native expanded conformation for the wtVLP. Our work not only validates the yeast-produced PV2 sVLP as a promising vaccine candidate with high production potential but also sheds light on the structural mechanisms that underpin the assembly and immunogenicity of the PV2 sVLP. These findings may expedite the development of sVLP-based PV vaccines.
PubMed: 39340107
DOI: 10.3390/vaccines12091077
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.1 Å)
構造検証レポート
Validation report summary of 8zb6
検証レポート(詳細版)ダウンロードをダウンロード

239149

件を2025-07-23に公開中

PDB statisticsPDBj update infoContact PDBjnumon